Tag: 3BL

VANCOUVER, British Columbia, JUNE 10, 2026, /3BL/ –DP World has successfully achieved Green Marine recertification across four of its Canadian terminals, reinforcing its commitment to environmental stewardship and continuous improvement across port operations.

The results build on DP World’s growing participation in the Green Marine program. In November 2024, the company expanded its membership to include terminals in Vancouver, Nanaimo, and Saint John. These additional terminals joined Prince Rupert, which has been Green Marine certified since 2013. This expansion marked a significant step in scaling a consistent, measurable approach to sustainability across DP World’s Canadian network.

David Bolduc, Green Marine International President and CEO, said: “DP World’s latest Green Marine results clearly demonstrate how a long-term, structured approach to environmental performance can deliver tangible gains across an entire terminal network. Seeing multiple facilities reach the highest levels in areas like air emissions and community impacts is a strong signal of leadership to the wider marine industry, and exactly the kind of continual improvement our program is designed to foster.”

Green Marine is a voluntary, third-party verified environmental certification program for ports, terminals, shipyards and ship owners in North America, with a similar framework in Europe. It also certifies participants in Australia. The program evaluates participants across a range of environmental performance indicators – including air emissions, community impacts, waste management, and spill prevention – using a five-level scale.

Level 1 represents regulatory compliance, while Level 5 reflects industry-leading performance and excellence.

Strong Results Across the Network

Across its terminals, DP World delivered consistent performance in core environmental indicators, with particularly strong results in air emissions and community impacts:

• Vancouver and Prince Rupert led the network, each achieving Level 5 – the highest possible rating – in both Air Emissions and Community Impacts, supported by Level 4 performance across community relations, environmental leadership, and spill prevention, and Level 3 in waste management.
• At Nanaimo, the terminal achieved Level 5 in Air Emissions and Level 4 in both Community Impacts and Community Relations, establishing a strong baseline for future progress, with opportunities identified in areas such as spill prevention and stormwater management.
• Meanwhile, Saint John demonstrated consistent, well-established performance, achieving Level 4 across four key indicators – Air Emissions, Community Impacts, Community Relations, and Environmental Leadership – alongside Level 3 in waste management and spill prevention.

Doug Smith, CEO of DP World in Canada, said: “Green Marine provides a clear, credible framework to measure and continuously improve our environmental performance across our operations. These results reflect the strength of our teams on the ground and our commitment to operating responsibly while delivering for our customers and partners. Just as importantly, strengthening environmental sustainability across our terminals enhances the long-term resilience of Canada’s supply chains – supporting the country’s ability to diversify trade, drive sustainable growth, and remain competitive in an evolving global market.”

Driving Performance Through Operational Excellence

The Green Marine verification process includes both a detailed document review and in-person site visits, ensuring that reported practices align closely with on-the-ground operations. Across all terminals, results are directly tied to day-to-day activities from emissions management and community engagement to waste handling and spill prevention.

Bronwyn Pountney, Environment Manager for DP World in Canada, said: “As with all Green Marine verifications, these results are a direct reflection of what happens day-to-day across our terminals. We’re proud of the progress we’ve made, particularly in areas like air emissions and community impacts, and we’re focused on building on this momentum to further strengthen our performance in the years ahead.”

By participating in Green Marine, DP World gains a structured framework to benchmark progress, set targets, and drive continuous improvement across its operations – ensuring sustainability remains embedded in every aspect of its business.

– END –

For more insights into how DP World is reshaping global trade, visit our website: www.dpworld.com

For media enquiries, please contact:

Melina Vissat, Head of Communications 
M: (+1) 704-605-6159 
E: melina.vissat@dpworld.com

About DP World

DP World is reshaping the future of global trade to improve lives everywhere. Operating across six continents with a team of over 125,000 employees, we combine global infrastructure and local expertise to deliver seamless supply chain solutions. From Ports and Terminals to Marine Services, Logistics and Technology, we leverage innovation to create better ways to trade, minimizing disruptions from the factory floor to the customer’s door.

In the Americas, DP World operates with a team of over 16,000 people across 12 countries, driving excellence through a robust network of 14 ports and terminals and more than 40 warehouses. By harnessing our global reach and local expertise, we simplify logistics, enhance operational performance, and redefine the boundaries of what’s possible in global trade.

WE MAKE TRADE FLOW.

ROCHESTER, Minn., June 10, 2026 /3BL/ – Urbaneer and the Well Living Lab recently hosted a networking event showcasing plans for the Home Innovation Lab (HIL), an innovative residential home designed to demonstrate how research, technology, and human-centered design can support healthier living environments and aging in place. The site will include a residential research environment focused on human-centered living as well as an experience center designed to evaluate emerging products and technologies in a real-world home setting.

Held at the Well Living Lab in downtown Rochester, Minnesota, in the heart of the Destination Medical Center (DMC) district, the event was planned in conjunction with DMC’s annual Real Estate & Investment Summit and welcomed developers, builders, healthcare leaders, researchers, and community stakeholders for conversations centered on the future of residential wellness and housing innovation.

Attendees explored the Home Innovation Lab renderings, educational displays, research insights, and interactive experiences highlighting how residential environments can better support health and well-being through evidence-based design. Key focus areas included indoor air quality, lighting, sleep, stress recovery, biophilic design, and technology-enabled solutions that support aging in place and long-term wellness.

“The Home Innovation Lab reflects the kind of forward-thinking collaboration that continues to position Rochester as a leader in innovation and as America’s City for Health,” said Patrick Seeb, Executive Director, DMC EDA. “As communities nationwide navigate evolving housing needs and demographic shifts, initiatives like this demonstrate how technology and cross-industry partnerships can help shape healthier homes and more resilient communities.”

“We are seeing a major shift in the market, with consumer demand rising fast for healthy homes, which we know can play a critical role supporting human health and well-being,” said Rachel Hodgdon, President and CEO, International WELL Building Institute. “Initiatives like the Home Innovation Lab — alongside the growing momentum behind WELL for residential — demonstrate how research, technology and thoughtful residential design can come together to support healthier living environments for people across every stage of life.”

Construction on the Home Innovation Lab is anticipated to begin in the fourth quarter of 2026, with the Lab expected to be fully operational by the second quarter of 2027.

# # #

About Urbaneer

Urbaneer is a wellness real estate and residential intelligence company focused on creating healthier, technology-enabled living environments that support comfort, safety, and well-being across all stages of life. With more than a decade of specialized expertise, Urbaneer has completed more than 30 residential projects across five states and continues to advance technology-driven approaches that support health and healthcare delivery within the home. For more information, visit urbaneerliving.com or contact Bruce Thompson, CEO, at bruce@urbaneerliving.com.

About the Well Living Lab

The Well Living Lab, founded in 2016 as a collaboration between Delos and Mayo Clinic, is the first research facility dedicated exclusively to studying the real-world impact of indoor environments on human health and well-being. To date, the Well Living Lab has completed 43 studies and generated 45 peer-reviewed publications, with formal academic affiliations including the University of Minnesota. For more information, visit welllivinglab.com or contact Barb Spurrier, Executive Director, at barbara.spurrier@delos.com.

Contact: Sarah Kelling, Director of Communications & Marketing, Well Living Lab

507.421.9864 | sarah.kelling@delos.com

Originally published on CVS Health Company Newsroom

WOONSOCKET, R.I., June 10, 2026 /3BL/ – CVS Health (NYSE: CVS) today announced updates to its most common commercial formularies, expanding GLP-1 options for members— including the reintroduction of Zepbound® (tirzepatide) as a covered medication. These changes build on Caremark’s industry leading efforts as a pharmacy benefits manager to explore all potential avenues that help patients get FDA-approved weight management medications at an affordable cost. Plan sponsors that adopt CVS Caremark template formularies retain discretion to customize coverage for their members.

What changes is CVS Caremark making to its weight management drug coverage?

CVS Caremark will add Zepbound back to our commercial formularies as an additional preferred option October 1, 2026, increasing access to GLP-1s at a more affordable price for plan sponsors who elect to provide coverage of those medications for their members. Additionally, effective June 1, 2026, CVS Caremark will remove the new-to-market block on Foundayo™(orforglipron), a new oral GLP-1 therapy, where approved for coverage by plans.

Over the past year, we’ve been actively driving change in the GLP-1 weight management space to help lower costs. Our approach has made a real difference, enabling us to now expand options while continuing to make progress on affordability.

We expect these changes to help drive increased savings in the weight management category – after a history of delivering double digit savings for our template formulary customers year over year – while expanding choice for our members.

Why is CVS Caremark adding Zepbound to their formulary?

Simply put, we achieved what our customers asked us for: deliver affordability and optionality in this important class.

“We’re creating access and options that would not have existed without our leadership in the market,” said Ed DeVaney, President, CVS Caremark. “We acted boldly through active engagement and negotiation with our drug manufacturer partners to tackle affordability and access for our customers and their members.”

What is CVS Caremark doing to bring down the cost of GLP-1s?

Over the past two years, high prices have put these therapies out of reach for the many people who could benefit from them. Last year, we took the initiative to drive engagement with manufacturers to bend the cost curve — similar to how we’ve helped improve affordability for drugs used for diabetes, high cholesterol, psoriasis, rheumatoid arthritis and many more. 

By acting early, we helped improve affordability and get ahead of a rapidly evolving GLP-1 pipeline. This past year, as this therapy class has continued to evolve, we worked with the manufacturers to secure a more affordable cost with positive results that allow us the flexibility to continue offering our customers more choice and access for their members.

What are the challenges with GLP-1 pricing?

While GLP-1s represent a major clinical advancement, the broad demand for a high-priced medicine creates a level of financial strain that is difficult to absorb at scale. As a result, many of our customers have made tough trade-offs, limiting coverage in order to maintain sustainable, balanced benefit programs. Ongoing collaboration with pharmaceutical companies is helping to make this in-demand drug class more accessible.

How was CVS Caremark able to lower the price of these weight management drugs?

As a pharmacy benefit manager, CVS Caremark is hired by businesses, big and small, health plans, unions, and government entities to negotiate the cost of medications included on formularies elected by plan sponsors that offer a benefit to their members. These negotiations have led us to deliver increased affordability and increased access to GLP-1s across the class.

What is a formulary and how does it impact patients?

A formulary is a list of prescription medications available under a health plan, managed with the support of a pharmacy benefit manager. CVS Caremark regularly evaluates formularies — which plan sponsors may adopt or customize based on the needs of their populations — to help support member access to clinically appropriate treatments as evaluated by an independent Pharmacy & Therapeutics committee while helping manage overall medication costs for customers and the members they serve. 

How is CVS Caremark supporting customers and members through these changes?

CVS Caremark will provide advanced communication and/or support to customers, consultants, providers and members to help ensure a smooth transition to covered therapies. These efforts include proactive outreach, educational resources, and clinical support programs. 

These formulary updates are one component of CVS Health’s ongoing efforts to address rising prescription drug costs and improve access to affordable medications for the millions of Americans it serves. 

About CVS Health

CVS Health is a leading health solutions company simplifying health care one person, one family and one community at a time. As of March 31, 2026, the Company had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics and a leading pharmacy benefits manager with approximately 88 million plan members. The Company also serves an estimated more than 37 million people through a broad range of health insurance products and related services. The Company’s integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.

Cautionary Statement Concerning Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation. Statements in this press release that are forward-looking include, but are not limited to, statements regarding the anticipated impact of the formulary changes on affordability, access, and member out-of-pocket costs, as well as statements regarding ongoing engagement with pharmaceutical manufacturers. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated by the forward-looking statements due to the risks and uncertainties described in CVS Health’s filings with the Securities and Exchange Commission, including those set forth in the Risk Factors section and under the heading “Cautionary Statement Concerning Forward-Looking Statements” in our most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, and Current Reports on Form 8-K. You are cautioned not to place undue reliance on CVS Health’s forward-looking statements. CVS Health does not assume any duty to update or revise forward-looking statements except as required by law.

Media Contact:

Phil Blando
Phillip.Blando@cvshealth.com

Originally published on CVS Health Company Newsroom

WOONSOCKET, R.I., June 10, 2026 /3BL/ – CVS Health (NYSE: CVS) today announced updates to its most common commercial formularies, expanding GLP-1 options for members— including the reintroduction of Zepbound® (tirzepatide) as a covered medication. These changes build on Caremark’s industry leading efforts as a pharmacy benefits manager to explore all potential avenues that help patients get FDA-approved weight management medications at an affordable cost. Plan sponsors that adopt CVS Caremark template formularies retain discretion to customize coverage for their members.

What changes is CVS Caremark making to its weight management drug coverage?

CVS Caremark will add Zepbound back to our commercial formularies as an additional preferred option October 1, 2026, increasing access to GLP-1s at a more affordable price for plan sponsors who elect to provide coverage of those medications for their members. Additionally, effective June 1, 2026, CVS Caremark will remove the new-to-market block on Foundayo™(orforglipron), a new oral GLP-1 therapy, where approved for coverage by plans.

Over the past year, we’ve been actively driving change in the GLP-1 weight management space to help lower costs. Our approach has made a real difference, enabling us to now expand options while continuing to make progress on affordability.

We expect these changes to help drive increased savings in the weight management category – after a history of delivering double digit savings for our template formulary customers year over year – while expanding choice for our members.

Why is CVS Caremark adding Zepbound to their formulary?

Simply put, we achieved what our customers asked us for: deliver affordability and optionality in this important class.

“We’re creating access and options that would not have existed without our leadership in the market,” said Ed DeVaney, President, CVS Caremark. “We acted boldly through active engagement and negotiation with our drug manufacturer partners to tackle affordability and access for our customers and their members.”

What is CVS Caremark doing to bring down the cost of GLP-1s?

Over the past two years, high prices have put these therapies out of reach for the many people who could benefit from them. Last year, we took the initiative to drive engagement with manufacturers to bend the cost curve — similar to how we’ve helped improve affordability for drugs used for diabetes, high cholesterol, psoriasis, rheumatoid arthritis and many more. 

By acting early, we helped improve affordability and get ahead of a rapidly evolving GLP-1 pipeline. This past year, as this therapy class has continued to evolve, we worked with the manufacturers to secure a more affordable cost with positive results that allow us the flexibility to continue offering our customers more choice and access for their members.

What are the challenges with GLP-1 pricing?

While GLP-1s represent a major clinical advancement, the broad demand for a high-priced medicine creates a level of financial strain that is difficult to absorb at scale. As a result, many of our customers have made tough trade-offs, limiting coverage in order to maintain sustainable, balanced benefit programs. Ongoing collaboration with pharmaceutical companies is helping to make this in-demand drug class more accessible.

How was CVS Caremark able to lower the price of these weight management drugs?

As a pharmacy benefit manager, CVS Caremark is hired by businesses, big and small, health plans, unions, and government entities to negotiate the cost of medications included on formularies elected by plan sponsors that offer a benefit to their members. These negotiations have led us to deliver increased affordability and increased access to GLP-1s across the class.

What is a formulary and how does it impact patients?

A formulary is a list of prescription medications available under a health plan, managed with the support of a pharmacy benefit manager. CVS Caremark regularly evaluates formularies — which plan sponsors may adopt or customize based on the needs of their populations — to help support member access to clinically appropriate treatments as evaluated by an independent Pharmacy & Therapeutics committee while helping manage overall medication costs for customers and the members they serve. 

How is CVS Caremark supporting customers and members through these changes?

CVS Caremark will provide advanced communication and/or support to customers, consultants, providers and members to help ensure a smooth transition to covered therapies. These efforts include proactive outreach, educational resources, and clinical support programs. 

These formulary updates are one component of CVS Health’s ongoing efforts to address rising prescription drug costs and improve access to affordable medications for the millions of Americans it serves. 

About CVS Health

CVS Health is a leading health solutions company simplifying health care one person, one family and one community at a time. As of March 31, 2026, the Company had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics and a leading pharmacy benefits manager with approximately 88 million plan members. The Company also serves an estimated more than 37 million people through a broad range of health insurance products and related services. The Company’s integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.

Cautionary Statement Concerning Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation. Statements in this press release that are forward-looking include, but are not limited to, statements regarding the anticipated impact of the formulary changes on affordability, access, and member out-of-pocket costs, as well as statements regarding ongoing engagement with pharmaceutical manufacturers. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated by the forward-looking statements due to the risks and uncertainties described in CVS Health’s filings with the Securities and Exchange Commission, including those set forth in the Risk Factors section and under the heading “Cautionary Statement Concerning Forward-Looking Statements” in our most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, and Current Reports on Form 8-K. You are cautioned not to place undue reliance on CVS Health’s forward-looking statements. CVS Health does not assume any duty to update or revise forward-looking statements except as required by law.

Media Contact:

Phil Blando
Phillip.Blando@cvshealth.com

Henkel manufacturing sites are proud to produce quality adhesive and consumer brands products that have become must-haves in homes and for businesses across North America, and around the world.

More than ever, our production teams are finding innovative ways to produce these high-quality products with less impact on the environment. In recognition of World Environment Day, we are proud to highlight a few of many sustainability success stories from Henkel’s front lines.

Adhesive Technologies

Enoree, South Carolina

Targeting the steam system’s heavy usage of energy and water, in October 2025 the team at Enoree installed energy-efficient upgrades to the boiler and steam traps, reducing natural gas and water consumption and contributing to the site’s water circularity goals. These upgrades are part of a three-phase plan to add efficiency measures throughout the steam system, which will ultimately save more than 8,000 MWh of electricity, 7,300 cubic meters of water and 1,400 metric tons of carbon dioxide emissions.

Warren, Michigan

Thirsty for water savings, the team in Warren developed a 3D printed spacer for use as the membrane in the site’s reverse osmosis (RO) water purification system, which feeds the deionization (DI) water system. Since installation of this RO element in October 2025, the site has seen improved DI water flow, reduced system pressure, and increases in overall water efficiency to the tune of 8,000+ cubic meters per year.

Mentor, Ohio

With production increasingly focused on silane modified polymer (SMP) adhesive products, the team in Mentor sought a cure for material waste. In the manufacturing process, once SMP material is exposed to moisture in the atmosphere, the material cures and cannot be re-worked. In the past, this led to large volumes of high-value material going to waste. In November 2025, the site installed an additional buffer press to reclaim previously scrapped material and slowly feed it back into the system. As a result, the site is now producing 272 fewer tons of waste every year and saving significantly in raw materials and disposal costs.

Brandon, South Dakota

When our Brandon facility doubled its size to better serve the evolving needs of the electric vehicle (EV) and electronics industries, sustainability became part of the blueprint. As a result, this flagship facility became the first in Henkel’s North American Adhesive Technologies business to achieve a LEED® (Leadership in Energy and Environmental Design) certification, the most widely recognized green building rating system. The Brandon plant’s LEED Silver status reflects enhanced performance in sustainability, energy efficiency, water conservation, indoor environmental quality, and waste management. 

“Finding more efficient ways to make quality products is an integral part of our plant teams’ focus across both businesses. As we celebrate Henkel’s 150th anniversary in 2026, we are excited to bring our founder’s pioneering spirit to building a legacy of conservation for the generations to come.”
– Bjoern Jackisch, Senior Vice President Operations and Supply Chain, Henkel Adhesive Technologies

Henkel Consumer Brands

St. Louis, Missouri

At our consumer brands St. Louis facility, which produces ingredients used in laundry detergents, the wastewater pretreatment process is particularly challenging due to the onsite sulfonation chemical manufacturing process. The plant’s commitment to environmental responsibility and outstanding efforts to protect public water quality through effective wastewater pretreatment earned Henkel the prestigious 2025 Gold Award from the Missouri Water Environment Association (MWEA).

Bowling Green, Kentucky

The 2025 launch of concentrated laundry detergent formulas and smaller, more sustainable bottles recently earned Henkel the American Cleaning Institute’s 2026 Sustainability Spotlight Award. At the Bowling Green consumer brands facility, concentrated formulas were introduced across the all® free clear, Persil® and Snuggle® brands. This effort helped reduce water usage by 9 million gallons of water a year, while redesigned packaging reduced net plastic use by 5% and increased shipping efficiency, resulting in fewer trucks on the road.

“Our manufacturing plants are at the heart of Henkel’s sustainability journey, where innovation meets execution every day. By empowering our teams to rethink processes, reduce resource consumption, and scale impactful solutions, we are driving measurable progress toward our sustainability goals while continuing to deliver high-quality products to our customers.”
– Gianmatteo Cingano, Vice President of Manufacturing, Henkel Consumer Brands

These sustainability success stories are just a few ways Henkel employees are leveraging technology and outside-the-box thinking to make manufacturing processes more sustainable.

Henkel manufacturing sites are proud to produce quality adhesive and consumer brands products that have become must-haves in homes and for businesses across North America, and around the world.

More than ever, our production teams are finding innovative ways to produce these high-quality products with less impact on the environment. In recognition of World Environment Day, we are proud to highlight a few of many sustainability success stories from Henkel’s front lines.

Adhesive Technologies

Enoree, South Carolina

Targeting the steam system’s heavy usage of energy and water, in October 2025 the team at Enoree installed energy-efficient upgrades to the boiler and steam traps, reducing natural gas and water consumption and contributing to the site’s water circularity goals. These upgrades are part of a three-phase plan to add efficiency measures throughout the steam system, which will ultimately save more than 8,000 MWh of electricity, 7,300 cubic meters of water and 1,400 metric tons of carbon dioxide emissions.

Warren, Michigan

Thirsty for water savings, the team in Warren developed a 3D printed spacer for use as the membrane in the site’s reverse osmosis (RO) water purification system, which feeds the deionization (DI) water system. Since installation of this RO element in October 2025, the site has seen improved DI water flow, reduced system pressure, and increases in overall water efficiency to the tune of 8,000+ cubic meters per year.

Mentor, Ohio

With production increasingly focused on silane modified polymer (SMP) adhesive products, the team in Mentor sought a cure for material waste. In the manufacturing process, once SMP material is exposed to moisture in the atmosphere, the material cures and cannot be re-worked. In the past, this led to large volumes of high-value material going to waste. In November 2025, the site installed an additional buffer press to reclaim previously scrapped material and slowly feed it back into the system. As a result, the site is now producing 272 fewer tons of waste every year and saving significantly in raw materials and disposal costs.

Brandon, South Dakota

When our Brandon facility doubled its size to better serve the evolving needs of the electric vehicle (EV) and electronics industries, sustainability became part of the blueprint. As a result, this flagship facility became the first in Henkel’s North American Adhesive Technologies business to achieve a LEED® (Leadership in Energy and Environmental Design) certification, the most widely recognized green building rating system. The Brandon plant’s LEED Silver status reflects enhanced performance in sustainability, energy efficiency, water conservation, indoor environmental quality, and waste management. 

“Finding more efficient ways to make quality products is an integral part of our plant teams’ focus across both businesses. As we celebrate Henkel’s 150th anniversary in 2026, we are excited to bring our founder’s pioneering spirit to building a legacy of conservation for the generations to come.”
– Bjoern Jackisch, Senior Vice President Operations and Supply Chain, Henkel Adhesive Technologies

Henkel Consumer Brands

St. Louis, Missouri

At our consumer brands St. Louis facility, which produces ingredients used in laundry detergents, the wastewater pretreatment process is particularly challenging due to the onsite sulfonation chemical manufacturing process. The plant’s commitment to environmental responsibility and outstanding efforts to protect public water quality through effective wastewater pretreatment earned Henkel the prestigious 2025 Gold Award from the Missouri Water Environment Association (MWEA).

Bowling Green, Kentucky

The 2025 launch of concentrated laundry detergent formulas and smaller, more sustainable bottles recently earned Henkel the American Cleaning Institute’s 2026 Sustainability Spotlight Award. At the Bowling Green consumer brands facility, concentrated formulas were introduced across the all® free clear, Persil® and Snuggle® brands. This effort helped reduce water usage by 9 million gallons of water a year, while redesigned packaging reduced net plastic use by 5% and increased shipping efficiency, resulting in fewer trucks on the road.

“Our manufacturing plants are at the heart of Henkel’s sustainability journey, where innovation meets execution every day. By empowering our teams to rethink processes, reduce resource consumption, and scale impactful solutions, we are driving measurable progress toward our sustainability goals while continuing to deliver high-quality products to our customers.”
– Gianmatteo Cingano, Vice President of Manufacturing, Henkel Consumer Brands

These sustainability success stories are just a few ways Henkel employees are leveraging technology and outside-the-box thinking to make manufacturing processes more sustainable.

Originally published on Aflac Newsroom

When it comes to cancer, progress is often measured not only by new treatments, but by how early the disease can be found. For Ryan Schoenfeld, Ph.D., CEO of The Mark Foundation for Cancer Research, that distinction has become a defining focus — one that is reshaping how scientists, funders and institutions work together to confront some of cancer’s most urgent challenges.

At the helm of the New York-based philanthropic organization, Dr. Schoenfeld is championing an approach grounded in collective action. While advances in treatment have improved survival rates for many cancers, some of the most deadly — such as pancreatic, ovarian and liver cancers — remain notoriously difficult to identify early. Symptoms often appear late, and reliable screening tools are limited or nonexistent. The result is a sobering reality: Too many patients are diagnosed only after the disease has progressed.

For Dr. Schoenfeld, addressing this gap is among the most pressing trials in modern oncology. Tackling this truth is why Dr. Schoenfeld has been recognized as an Aflac Check for Cancer Champion.

Building a new model of collaboration and turning breakthroughs into reality

This philosophy recently took shape through a new coalition, led by The Mark Foundation and launched to advance early detection tools for the world’s most difficult-to-diagnose cancers.

The coalition, which also includes the American Association for Cancer Research, Lustgarten Foundation, Break Through Cancer, and The Honorable Tina Brozman Foundation (Tina’s Wish), has so far invested $12 million in six collaborative research projects focused on pancreatic, ovarian and esophageal cancers, as well as cancer predisposition syndromes.

The grant program represents a notable shift in approach. Historically, research efforts have often unfolded in parallel, with funders and institutions pursuing similar goals independently. The coalition upends that paradigm by bringing together philanthropic organizations, scientists and research institutions to align resources, share knowledge and accelerate progress.

By fostering collaboration at this scale, the coalition aims to overcome one of the field’s greatest obstacles, which is not a lack of scientific ingenuity, but the fragmentation that can slow its application.

Dr. Schoenfeld sees this unified strategy as essential.

“I’m proud to lead a foundation that prioritizes the ‘big swings’ in science, and to work alongside a coalition of partners and scientists who are working tirelessly to make early detection a clinical reality,” Dr. Schoenfeld said. “We can’t cure what we can’t detect, and initiatives like Aflac’s Check for Cancer highlights the urgent need to work together to ensure that every patient benefits from an early, lifesaving diagnosis.”

The coalition’s focus on early detection comes at a pivotal moment. Advances in fields such as genomics, biomarker discovery and artificial intelligence are opening new pathways for identifying cancer long before symptoms emerge. Yet significant challenges remain in translating these discoveries into practical, widely accessible screening tools.

By aligning funding and expertise, Dr. Schoenfeld and his partners hope to bridge that divide, moving promising science out of the lab and into clinical use more quickly.

A shared commitment to patients

Despite the complexity of the scientific challenges, Dr. Schoenfeld remains focused on the human stakes. Every initiative, every partnership and every grant ultimately ties back to a single goal: improving outcomes for patients and their families, because for them, the potential impact is profound. Early detection not only increases survival rates but can also expand treatment options and improve quality of life. It shifts cancer care from reactive to proactive, offering a chance to intervene before the disease takes hold.

Looking ahead, Dr. Schoenfeld is both realistic and hopeful. Progress will require sustained effort, continued collaboration and an openness to rethinking long-standing approaches. In that sense, his work is less about singular breakthroughs and more about building a system capable of delivering them faster, more effectively and for the benefit of all. And for Dr. Schoenfeld, that vision — of catching cancer earlier, when it can be treated and even cured — is one worth pursuing with unwavering determination. It is the vision of a champion.

The Check for Cancer Champions program is part of Aflac’s Check for Cancer initiative, a bold, national movement to increase cancer screenings by 10% over 10 years. Learn more about the Check for Cancer movement by visiting Aflac.com/CheckForCancer.

Aflac WWHQ | 1932 Wynnton Road | Columbus, GA 31999

Z2600376
EXP 6/27

The Seattle Mariners solid start to the 2026 season is already giving fans plenty to cheer about the partnership with KeyBank is adding even more excitement to the club’s milestone 50th anniversary celebration.

This season, KeyBank is presenting sponsor of the Seattle Mariners 50^th Season Pin Series, a season-long promotion that invites fans to celebrate each decade of Mariners baseball through exclusive commemorative pins. These have been a must-have for longtime supporters and collectors alike.

On Monday, June 15^th, collectors can visit any of the five participating KeyBank branches to collect the KeyBank Exclusive, branch-only pin while supplies last. This special release is designed specifically for in-person visitors and not available at the stadium. The promotion offers fans an added incentive to engage with local branches while securing a key piece of the commemorative series while supplies last. Participating branches include:

• Wedgewood
• Overlake
• Westlake
• Mill Creek
• Bonney Lake

Additional pins representing each era of Mariners history will continue to roll out throughout the season, with availability split between select home games and these participating KeyBank locations. 

• July 19 – ‘00s Pin Day
• August 9 – 50 Seasons Pin Day
• August 23 – ‘10s Pin Day
• September 26 – ‘20s Pin Day

Fans can get their seats at Mariners.com/Tickets.

This collaboration reflects a shared commitment between the Mariners and KeyBank to celebrate community, history, and fan loyalty during one of the most significant seasons in franchise history.

With the Mariners off to a promising start on the field and a lineup of fan-focused activations like the Eras Pin Series, the 2026 season is shaping up to be a memorable one across the Puget Sound region. Visit www.mariners.com/pins for more information. For more information, visit https://www.key.com/. KeyBank Member FDIC.

June 4^th 2026 –  In Inola, Oklahoma, Sofidel America held a groundbreaking ceremony – traditionally marking the start of construction in the United States – for the expansion of its integrated facility in Inola.

Joining Sofidel CEO Luigi Lazzareschi at the event were Oklahoma Lieutenant Governor Matt Pinnell, Inola Mayor Darlene Shear, and other local authorities.

The project, announced over the past few months and representing a total investment of $775 million, includes the construction of a new building to house a 75,000 tonnes per year Valmet Through-Air-Drying (TAD) tissue machine, along with the installation of converting lines with matching capacity, the expansion of the pulp and parent reel warehouse, and the construction of a fully automated finished goods warehouse with 100,000 pallet positions. Overall, approximately 1,000,000 square feet (90,000 square meters) of new built surface area will be developed.

Start-up of the new machine is scheduled for the second quarter of 2028. The Inola facility, fully operational since 2020, will increase its production capacity by more than 50%, reaching over 200,000 tonnes per year, becoming one of the Group’s main production sites globally.

This investment has also been made possible thanks to the strong relationships built over time with local institutions and communities, based on collaboration and continuous support.

In the year of its 60th anniversary, Sofidel is taking another strategic step in the United States to strengthen its offering of premium products and meet the growing demand of an expanding market.

Sofidel Group 

The Sofidel Group, headquartered in Porcari (Lucca, Italy), is one of the leading manufacturers of paper for hygienic and household use worldwide. Established in 1966, the Group is active in 13 countries, 12 in Europe and the United States (12 States), with over 9,500 employees and a production capacity of 2,002,000 metric tons per year. In 2025, the Group had Net Sales of 4.018 billion Euros. “Regina”, its most well-known brand, is present on almost all the reference markets. Other brands include: Sopalin, Le Trèfle, Hakle, Softis, Nalys, Cosynel, KittenSoft, Nicky and Papernet. 

www.sofidel.com

SLB and Ormat Technologies have selected Desert Peak in Nevada as the preferred location for a planned enhanced geothermal system (EGS) pilot, following a multi-site evaluation across existing geothermal fields.

Understanding subsurface conditions is critical to the successful industrialization of EGS activities. Early evaluation, modeling and simulation of subsurface conditions help reduce uncertainty because geology, stress conditions and heat distribution directly influence project feasibility and long-term reservoir performance.

SLB evaluated multiple Ormat-operated geothermal fields across Nevada using an integrated subsurface workflow. The approach combined geological interpretation, geomechanical analysis and development inputs to enable consistent comparison across candidate sites and address key EGS challenges, including stimulation efficiency, fluid flow consistency, parasitic losses, water loss, and geochemical complications.

Desert Peak emerged as the strongest candidate based on its combination of technical potential and development practicality. The site also benefits from proximity to existing infrastructure, along with defined corridors for potential well placement between known structural features.

With the site selected, the appraisal phase will further refine the development concept and reduce remaining uncertainty. Planned activities include new magnetotelluric and seismic surveys to support development of a 3D mechanical earth model for fracture, thermal, hydraulic and mechanical analysis, as well as optimized well placement and stimulation program design.

This approach reflects SLB and Ormat’s view that a focus on structured, data-driven evaluation is needed to improve development predictability and reduce execution risk in complex geothermal environments, and to scale and industrialize EGS. The work builds on the companies’ October 2025 agreement to co-develop integrated geothermal assets and progress EGS from pilot to commercial deployment.

View original content here.